0.007900
0.000000
0.000000
0.000000
0.007900
0.000000
0.000000
0.000000
0.009879
0.00000
0.00000
0.00000
Gallop, J.L.
Kent, H.M.
Mcmahon, H.T.
Evans, P.R.
http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic
8
90.00
90.00
90.00
126.578
126.578
101.226
C3 H7 N O2
89.093
y
ALANINE
L-peptide linking
C6 H15 N4 O2 1
175.209
y
ARGININE
L-peptide linking
C4 H8 N2 O3
132.118
y
ASPARAGINE
L-peptide linking
C4 H7 N O4
133.103
y
ASPARTIC ACID
L-peptide linking
C3 H7 N O2 S
121.158
y
CYSTEINE
L-peptide linking
C5 H10 N2 O3
146.144
y
GLUTAMINE
L-peptide linking
C5 H9 N O4
147.129
y
GLUTAMIC ACID
L-peptide linking
C2 H5 N O2
75.067
y
GLYCINE
peptide linking
C6 H10 N3 O2 1
156.162
y
HISTIDINE
L-peptide linking
C6 H13 N O2
131.173
y
ISOLEUCINE
L-peptide linking
C6 H13 N O2
131.173
y
LEUCINE
L-peptide linking
C6 H15 N2 O2 1
147.195
y
LYSINE
L-peptide linking
C5 H11 N O2 Se
196.106
n
SELENOMETHIONINE
L-peptide linking
C9 H11 N O2
165.189
y
PHENYLALANINE
L-peptide linking
C5 H9 N O2
115.130
y
PROLINE
L-peptide linking
C3 H7 N O3
105.093
y
SERINE
L-peptide linking
C4 H9 N O3
119.119
y
THREONINE
L-peptide linking
C9 H11 N O3
181.189
y
TYROSINE
L-peptide linking
C5 H11 N O2
117.146
y
VALINE
L-peptide linking
UK
Embo J.
EMJODG
0897
0261-4189
25
2898
10.1038/SJ.EMBOJ.7601174
16763559
Mechanism of Endophilin N-Bar Domain-Mediated Membrane Curvature.
2006
1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
100.0
1
CCD
2004-11-05
ADSC CCD
MAD
M
x-ray
1
0.98
1.0
ID29
ESRF
0.98
SYNCHROTRON
ESRF BEAMLINE ID29
24025.070
SH3-CONTAINING GRB2-LIKE PROTEIN 2
2.3.1.-
BAR DOMAIN, RESIDUES 1-143
1
man
polymer
ENDOPHILIN A1, SH3 DOMAIN PROTEIN 2A, SH3P4
no
yes
EGTKLDDDFKE(MSE)ERKVDVTSRAV(MSE)EI(MSE)TKTIEYLQPNPASRAKPQAEALLAEA(MSE)LKFGRELGDD
CNFGPALGEVGEA(MSE)RELSEVKDSLD(MSE)EVKQNFIDPLQNLHDKDLREIQHHLKKLEGRRLDFDYKKKRQGKIP
DEELRQALEKFDESKEIAESS(MSE)FNLLE(MSE)DIEQVSQLSALVQAQLEYHKQAVQILQQVTVRLEERIRQA
EGTKLDDDFKEMERKVDVTSRAVMEIMTKTIEYLQPNPASRAKPQAEALLAEAMLKFGRELGDDCNFGPALGEVGEAMRE
LSEVKDSLDMEVKQNFIDPLQNLHDKDLREIQHHLKKLEGRRLDFDYKKKRQGKIPDEELRQALEKFDESKEIAESSMFN
LLEMDIEQVSQLSALVQAQLEYHKQAVQILQQVTVRLEERIRQA
A
polypeptide(L)
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
RAT
sample
10116
RATTUS NORVEGICUS
511693
ESCHERICHIA COLI
BL21
PLASMID
1
8.76
85.85
8.00
25% BUTANE-1,4-DIOL, 100MM TRIS PH 8.0,4DEGC, CRYOPROTECTED IN 40% BUTANE-1,4-DIOL, 25% ETHYLENE GLYCOL
277
exptl_crystal_grow
pdbx_database_proc
pdbx_database_status
struct_biol
struct_conn
repository
Initial release
Version format compliance
Version format compliance
Data collection
Derived calculations
Experimental preparation
Other
1
0
2006-06-14
1
1
2011-05-08
1
2
2011-07-13
1
3
2019-05-29
_exptl_crystal_grow.temp
_pdbx_database_status.recvd_author_approval
_struct_conn.pdbx_leaving_atom_flag
PDBE
Y
PDBE
2005-08-26
REL
UNIPROT DOES NOT CURRENTLY HAVE A FULL-LENGTH ENTRY
FOR RAT ENDOPHILIN A1. THE FRAGMENTS FROM 25-104
HAS BEEN MAPPED TO ITSELF AT THE PRESENT TIME DUE
TO A LACK OF AVAILABLE SEQUENCE DATABASE MAPPING
GLU
25
n
1
GLU
25
A
GLY
26
n
2
GLY
26
A
THR
27
n
3
THR
27
A
LYS
28
n
4
LYS
28
A
LEU
29
n
5
LEU
29
A
ASP
30
n
6
ASP
30
A
ASP
31
n
7
ASP
31
A
ASP
32
n
8
ASP
32
A
PHE
33
n
9
PHE
33
A
LYS
34
n
10
LYS
34
A
GLU
35
n
11
GLU
35
A
MSE
36
n
12
MSE
36
A
GLU
37
n
13
GLU
37
A
ARG
38
n
14
ARG
38
A
LYS
39
n
15
LYS
39
A
VAL
40
n
16
VAL
40
A
ASP
41
n
17
ASP
41
A
VAL
42
n
18
VAL
42
A
THR
43
n
19
THR
43
A
SER
44
n
20
SER
44
A
ARG
45
n
21
ARG
45
A
ALA
46
n
22
ALA
46
A
VAL
47
n
23
VAL
47
A
MSE
48
n
24
MSE
48
A
GLU
49
n
25
GLU
49
A
ILE
50
n
26
ILE
50
A
MSE
51
n
27
MSE
51
A
THR
52
n
28
THR
52
A
LYS
53
n
29
LYS
53
A
THR
54
n
30
THR
54
A
ILE
55
n
31
ILE
55
A
GLU
56
n
32
GLU
56
A
TYR
57
n
33
TYR
57
A
LEU
58
n
34
LEU
58
A
GLN
59
n
35
GLN
59
A
PRO
60
n
36
PRO
60
A
ASN
61
n
37
ASN
61
A
PRO
62
n
38
PRO
62
A
ALA
63
n
39
ALA
63
A
SER
64
n
40
SER
64
A
ARG
65
n
41
ARG
65
A
ALA
66
n
42
ALA
66
A
LYS
67
n
43
LYS
67
A
PRO
87
n
44
PRO
87
A
GLN
88
n
45
GLN
88
A
ALA
89
n
46
ALA
89
A
GLU
90
n
47
GLU
90
A
ALA
91
n
48
ALA
91
A
LEU
92
n
49
LEU
92
A
LEU
93
n
50
LEU
93
A
ALA
94
n
51
ALA
94
A
GLU
95
n
52
GLU
95
A
ALA
96
n
53
ALA
96
A
MSE
97
n
54
MSE
97
A
LEU
98
n
55
LEU
98
A
LYS
99
n
56
LYS
99
A
PHE
100
n
57
PHE
100
A
GLY
101
n
58
GLY
101
A
ARG
102
n
59
ARG
102
A
GLU
103
n
60
GLU
103
A
LEU
104
n
61
LEU
104
A
GLY
105
n
62
GLY
105
A
ASP
106
n
63
ASP
106
A
ASP
107
n
64
ASP
107
A
CYS
108
n
65
CYS
108
A
ASN
109
n
66
ASN
109
A
PHE
110
n
67
PHE
110
A
GLY
111
n
68
GLY
111
A
PRO
112
n
69
PRO
112
A
ALA
113
n
70
ALA
113
A
LEU
114
n
71
LEU
114
A
GLY
115
n
72
GLY
115
A
GLU
116
n
73
GLU
116
A
VAL
117
n
74
VAL
117
A
GLY
118
n
75
GLY
118
A
GLU
119
n
76
GLU
119
A
ALA
120
n
77
ALA
120
A
MSE
121
n
78
MSE
121
A
ARG
122
n
79
ARG
122
A
GLU
123
n
80
GLU
123
A
LEU
124
n
81
LEU
124
A
SER
125
n
82
SER
125
A
GLU
126
n
83
GLU
126
A
VAL
127
n
84
VAL
127
A
LYS
128
n
85
LYS
128
A
ASP
129
n
86
ASP
129
A
SER
130
n
87
SER
130
A
LEU
131
n
88
LEU
131
A
ASP
132
n
89
ASP
132
A
MSE
133
n
90
MSE
133
A
GLU
134
n
91
GLU
134
A
VAL
135
n
92
VAL
135
A
LYS
136
n
93
LYS
136
A
GLN
137
n
94
GLN
137
A
ASN
138
n
95
ASN
138
A
PHE
139
n
96
PHE
139
A
ILE
140
n
97
ILE
140
A
ASP
141
n
98
ASP
141
A
PRO
142
n
99
PRO
142
A
LEU
143
n
100
LEU
143
A
GLN
144
n
101
GLN
144
A
ASN
145
n
102
ASN
145
A
LEU
146
n
103
LEU
146
A
HIS
147
n
104
HIS
147
A
ASP
148
n
105
ASP
148
A
LYS
149
n
106
LYS
149
A
ASP
150
n
107
ASP
150
A
LEU
151
n
108
LEU
151
A
ARG
152
n
109
ARG
152
A
GLU
153
n
110
GLU
153
A
ILE
154
n
111
ILE
154
A
GLN
155
n
112
GLN
155
A
HIS
156
n
113
HIS
156
A
HIS
157
n
114
HIS
157
A
LEU
158
n
115
LEU
158
A
LYS
159
n
116
LYS
159
A
LYS
160
n
117
LYS
160
A
LEU
161
n
118
LEU
161
A
GLU
162
n
119
GLU
162
A
GLY
163
n
120
GLY
163
A
ARG
164
n
121
ARG
164
A
ARG
165
n
122
ARG
165
A
LEU
166
n
123
LEU
166
A
ASP
167
n
124
ASP
167
A
PHE
168
n
125
PHE
168
A
ASP
169
n
126
ASP
169
A
TYR
170
n
127
TYR
170
A
LYS
171
n
128
LYS
171
A
LYS
172
n
129
LYS
172
A
LYS
173
n
130
LYS
173
A
ARG
174
n
131
ARG
174
A
GLN
175
n
132
GLN
175
A
GLY
176
n
133
GLY
176
A
LYS
177
n
134
LYS
177
A
ILE
178
n
135
ILE
178
A
PRO
179
n
136
PRO
179
A
ASP
180
n
137
ASP
180
A
GLU
181
n
138
GLU
181
A
GLU
182
n
139
GLU
182
A
LEU
183
n
140
LEU
183
A
ARG
184
n
141
ARG
184
A
GLN
185
n
142
GLN
185
A
ALA
186
n
143
ALA
186
A
LEU
187
n
144
LEU
187
A
GLU
188
n
145
GLU
188
A
LYS
189
n
146
LYS
189
A
PHE
190
n
147
PHE
190
A
ASP
191
n
148
ASP
191
A
GLU
192
n
149
GLU
192
A
SER
193
n
150
SER
193
A
LYS
194
n
151
LYS
194
A
GLU
195
n
152
GLU
195
A
ILE
196
n
153
ILE
196
A
ALA
197
n
154
ALA
197
A
GLU
198
n
155
GLU
198
A
SER
199
n
156
SER
199
A
SER
200
n
157
SER
200
A
MSE
201
n
158
MSE
201
A
PHE
202
n
159
PHE
202
A
ASN
203
n
160
ASN
203
A
LEU
204
n
161
LEU
204
A
LEU
205
n
162
LEU
205
A
GLU
206
n
163
GLU
206
A
MSE
207
n
164
MSE
207
A
ASP
208
n
165
ASP
208
A
ILE
209
n
166
ILE
209
A
GLU
210
n
167
GLU
210
A
GLN
211
n
168
GLN
211
A
VAL
212
n
169
VAL
212
A
SER
213
n
170
SER
213
A
GLN
214
n
171
GLN
214
A
LEU
215
n
172
LEU
215
A
SER
216
n
173
SER
216
A
ALA
217
n
174
ALA
217
A
LEU
218
n
175
LEU
218
A
VAL
219
n
176
VAL
219
A
GLN
220
n
177
GLN
220
A
ALA
221
n
178
ALA
221
A
GLN
222
n
179
GLN
222
A
LEU
223
n
180
LEU
223
A
GLU
224
n
181
GLU
224
A
TYR
225
n
182
TYR
225
A
HIS
226
n
183
HIS
226
A
LYS
227
n
184
LYS
227
A
GLN
228
n
185
GLN
228
A
ALA
229
n
186
ALA
229
A
VAL
230
n
187
VAL
230
A
GLN
231
n
188
GLN
231
A
ILE
232
n
189
ILE
232
A
LEU
233
n
190
LEU
233
A
GLN
234
n
191
GLN
234
A
GLN
235
n
192
GLN
235
A
VAL
236
n
193
VAL
236
A
THR
237
n
194
THR
237
A
VAL
238
n
195
VAL
238
A
ARG
239
n
196
ARG
239
A
LEU
240
n
197
LEU
240
A
GLU
241
n
198
GLU
241
A
GLU
242
n
199
GLU
242
A
ARG
243
n
200
ARG
243
A
ILE
244
n
201
ILE
244
A
ARG
245
n
202
ARG
245
A
GLN
246
n
203
GLN
246
A
ALA
247
n
204
ALA
247
A
author_and_software_defined_assembly
PQS
2
dimeric
A
MSE
36
SELENOMETHIONINE
A
MSE
12
MET
A
MSE
48
SELENOMETHIONINE
A
MSE
24
MET
A
MSE
51
SELENOMETHIONINE
A
MSE
27
MET
A
MSE
97
SELENOMETHIONINE
A
MSE
54
MET
A
MSE
121
SELENOMETHIONINE
A
MSE
78
MET
A
MSE
133
SELENOMETHIONINE
A
MSE
90
MET
A
MSE
201
SELENOMETHIONINE
A
MSE
158
MET
A
MSE
207
SELENOMETHIONINE
A
MSE
164
MET
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
1_555
x,y,z
identity operation
0.0000000000
0.0000000000
0.0000000000
-1.0000000000
0.0000000000
0.0000000000
0.0000000000
-1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
6_665
-x+1,-y+1,z
crystal symmetry operation
126.5780000000
126.5780000000
0.0000000000
1
A
A
C
N
LYS
PRO
67
87
12.45
1
A
LYS
28
65.96
120.54
1
A
SER
64
-160.03
71.44
1
A
ALA
66
-54.63
103.70
1
A
CYS
108
-87.22
-156.50
1
A
PHE
139
-134.13
-55.77
1
A
ASP
148
-68.91
-81.39
1
A
LYS
149
-50.24
-79.52
1
A
ARG
174
-91.13
34.64
59.79
0.32000
0.00000
0.00000
0.32000
0.00000
-0.65000
0.881
0.861
HYDROGENS HAVE BEEN ADDED IN THE RIDING POSITIONS.
0.295
0.279
0.280
2.90
89.44
904
16875
5.100
99.9
12.411
0.228
RANDOM
1
THROUGHOUT
MAD
0.330
0.273
0.80
0.80
1.20
MAXIMUM LIKELIHOODWITH PHASES
MASK
2.90
89.44
0
1653
0
0
1653
0.020
0.023
1820
0.956
1.985
2234
4.461
5.000
202
35.810
25.556
90
17.836
15.000
346
14.325
15.000
13
0.072
0.200
245
0.003
0.020
1242
0.235
0.200
708
0.293
0.200
1169
0.128
0.200
23
0.172
0.200
53
0.080
0.200
4
0.595
1.500
1193
0.696
2.000
1629
1.239
3.000
675
1.833
4.500
605
0.3380
0.3610
2.98
65
1235
20
2.900
44.000
2C08
393336
6.000
0.16000
1
19.8000
22.100
99.9
0.95000
2.90
3.06
3.600
1
22.30
100.0
refinement
REFMAC
5.2.0005
data reduction
MOSFLM
data scaling
SCALA
phasing
SHARP
SH3-CONTAINING GRB2-LIKE PROTEIN 2 (E.C.2.3.1.-)
Rat endophilin A1 BAR domain
1
N
N
A
ASP
30
A
ASP
6
HELX_P
A
GLN
59
A
GLN
35
1
1
30
A
ASN
61
A
ASN
37
HELX_P
A
ARG
65
A
ARG
41
5
2
5
A
GLN
88
A
GLN
45
HELX_P
A
GLY
105
A
GLY
62
1
3
18
A
ASN
109
A
ASN
66
HELX_P
A
PHE
139
A
PHE
96
1
4
31
A
PHE
139
A
PHE
96
HELX_P
A
ARG
174
A
ARG
131
1
5
36
A
PRO
179
A
PRO
136
HELX_P
A
GLU
206
A
GLU
163
1
6
28
A
MSE
207
A
MSE
164
HELX_P
A
GLN
246
A
GLN
203
1
7
40
covale
1.327
both
A
GLU
35
A
C
GLU
11
1_555
A
MSE
36
A
N
MSE
12
1_555
covale
1.334
both
A
MSE
36
A
C
MSE
12
1_555
A
GLU
37
A
N
GLU
13
1_555
covale
1.334
both
A
VAL
47
A
C
VAL
23
1_555
A
MSE
48
A
N
MSE
24
1_555
covale
1.332
both
A
MSE
48
A
C
MSE
24
1_555
A
GLU
49
A
N
GLU
25
1_555
covale
1.329
both
A
ILE
50
A
C
ILE
26
1_555
A
MSE
51
A
N
MSE
27
1_555
covale
1.335
both
A
MSE
51
A
C
MSE
27
1_555
A
THR
52
A
N
THR
28
1_555
covale
1.331
both
A
ALA
96
A
C
ALA
53
1_555
A
MSE
97
A
N
MSE
54
1_555
covale
1.330
both
A
MSE
97
A
C
MSE
54
1_555
A
LEU
98
A
N
LEU
55
1_555
covale
1.336
both
A
ALA
120
A
C
ALA
77
1_555
A
MSE
121
A
N
MSE
78
1_555
covale
1.333
both
A
MSE
121
A
C
MSE
78
1_555
A
ARG
122
A
N
ARG
79
1_555
covale
1.335
both
A
ASP
132
A
C
ASP
89
1_555
A
MSE
133
A
N
MSE
90
1_555
covale
1.330
both
A
MSE
133
A
C
MSE
90
1_555
A
GLU
134
A
N
GLU
91
1_555
covale
1.330
both
A
SER
200
A
C
SER
157
1_555
A
MSE
201
A
N
MSE
158
1_555
covale
1.330
both
A
MSE
201
A
C
MSE
158
1_555
A
PHE
202
A
N
PHE
159
1_555
covale
1.338
both
A
GLU
206
A
C
GLU
163
1_555
A
MSE
207
A
N
MSE
164
1_555
covale
1.329
both
A
MSE
207
A
C
MSE
164
1_555
A
ASP
208
A
N
ASP
165
1_555
TRANSFERASE
ENDOCYTOSIS, BAR DOMAIN, MEMBRANE CURVATURE, SH3 DOMAIN, ACYLTRANSFERASE, COILED COIL, LIPID-BINDING, MULTIGENE FAMILY, PHOSPHORYLATION, TRANSFERASE
2C08
PDB
1
2C08
SH3G2_RAT
UNP
1
O35179
25
67
2C08
25
67
2C08
A
1
1
43
87
104
2C08
87
104
2C08
A
1
44
61
1
143
2C08
105
247
O35179
A
2
62
204
80
I 41